Patents by Inventor Esther PORRAS DE FRANCISCO

Esther PORRAS DE FRANCISCO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 11969423
    Abstract: The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: April 30, 2024
    Assignees: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, BIOVERSYS AG
    Inventors: Esther Porras De Francisco, Modesto Jesús Remuiñan-Blanco, Marilyne Bourotte, Benoit Deprez, Nicolas Willand
  • Compounds
    Patent number: 11253499
    Abstract: The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by Mycobacterium, such as tuberculosis.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: February 22, 2022
    Assignees: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, BIOVERSYS AG
    Inventors: Esther Porras De Francisco, Modesto Jesús Remuiñan-Blanco, Marilyne Bourotte, Benoit Deprez, Geoffroy Dequirez, Nicolas Willand
  • Compounds
    Patent number: 11254689
    Abstract: The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: February 22, 2022
    Assignees: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, BIOVERSYS AG
    Inventors: Esther Porras De Francisco, Modesto Jesús Remuiñan-Blanco, Marilyne Bourotte, Benoit Deprez, Nicolas Willand
  • NOVEL COMPOUNDS
    Publication number: 20210032268
    Abstract: The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
    Type: Application
    Filed: August 15, 2018
    Publication date: February 4, 2021
    Applicants: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, BIOVERSYS AG
    Inventors: Esther PORRAS DE FRANCISCO, Modesto Jesús REMUIÑAN-BLANCO, Marilyne BOUROTTE, Benoit DEPREZ, Nicolas WILLAND
  • NOVEL COMPOUNDS
    Publication number: 20200253967
    Abstract: The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
    Type: Application
    Filed: August 15, 2018
    Publication date: August 13, 2020
    Inventors: Esther PORRAS DE FRANCISCO, Modesto Jesús REMUIÑAN-BLANCO, Marilyne BOUROTTE, Benoit DEPREZ, Nicolas WILLAND
  • NOVEL COMPOUNDS
    Publication number: 20200170997
    Abstract: The invention relates to compounds of Formula (I) and their use in therapy, for example in the treatment of mycobacterial infections or in the treatment of diseases caused by mycobacterium, such as tuberculosis.
    Type: Application
    Filed: August 15, 2018
    Publication date: June 4, 2020
    Inventors: Esther PORRAS DE FRANCISCO, Modesto Jesús REMUIÑAN-BLANCO, Marilyne BOUROTTE, Benoit DEPREZ, Geoffroy DEQUIREZ, Nicolas WILLAND